SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-24-001597
Filing Date
2024-01-16
Accepted
2024-01-16 13:41:27
Documents
1
Period of Report
2023-10-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4834
  Complete submission text file 0001209191-24-001597.txt   6266
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Issuer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 101 MAIN STREET, SUITE 1210 CAMBRIDGE MA 02142
Business Address
Requadt Scott (Reporting) CIK: 0001664852 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37410 | Film No.: 24534610